Navigation Links
McNeil Consumer Healthcare Announces Plans for New Dosing Instructions for TYLENOL® Products
Date:7/28/2011

as currently labeled. The company is working closely with other manufacturers of acetaminophen products to help ensure consistency in dosing instructions.  

In addition to the new dosing instructions on the OTC label, the makers of TYLENOL® recently launched Get Relief Responsibly™, a national initiative designed to educate consumers about the appropriate use of prescription and OTC medications, particularly those containing acetaminophen, and the importance of reading and following medication labels. As a part of this initiative, the TYLENOL® website has been enhanced to include interactive tools to help consumers identify products that contain acetaminophen (www.tylenol.com/getreliefresponsibly).  

McNeil also announced that it will be introducing Bottle Cap Messaging on select Extra Strength TYLENOL® products.  The Bottle Cap Messaging is a message printed directly on bottle caps to remind consumers to always read and follow the label instructions.  This messaging is planned to appear on select Extra Strength TYLENOL® caps starting in 2012.  

About McNeil Consumer Healthcare 

McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. markets a broad range of well-known and trusted OTC products in the United States, including its complete line of TYLENOL® (acetaminophen) products.  The TYLENOL® product line consists of hundreds of products across a variety of adult and pediatric pain categories including: arthritis pain, pain with accompanying sleeplessness and upper respiratory.  Other McNeil brands include BENADRYL® allergy medicines; IMODIUM® A-D anti-diarrheal; MOTRIN® IB; ROLAIDS® antacid products; SUDAFED® and SUDAFED PE® nasal decongestants; and ZYRTEC®
'/>"/>

SOURCE McNeil Consumer Healthcare
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Isis Earns $5 Million Milestone Payment From Ortho-McNeil, Inc. for Initiation of Phase 1 Study of ISIS 325568
2. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
3. McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP
4. AUDIO from Medialink and Ortho-McNeil-Janssen Pharmaceuticals Inc.: Getting Ready for Cold and Flu Season
5. McNeil Consumer Healthcare Announces a Voluntary Nationwide Recall of All Lots of TYLENOL(R) Arthritis Pain 100 Count With EZ-OPEN CAP
6. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Agrees to $75 Million Settlement for Topamax(R) False Claims Lawsuit
7. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Resolves Investigation of Past TOPAMAX(R) Marketing and Promotional Activities
8. Ortho-McNeil Pharmaceutical, LLC Pleads Guilty to Illegal Promotion of Topamax and is Sentenced to Criminal Fine of $6.14 Million
9. The Pittsburgh Life Sciences Greenhouse Congratulates Diamyd Medical on Its Agreement with Ortho-McNeil-Janssen Pharmaceuticals to Develop Diabetes Therapy
10. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Announces Oncology Research Collaboration Agreement with the Koch Institute for Integrative Cancer Research at MIT
11. McNeil Consumer Healthcare Announces Voluntary Recall of One Product Lot of TYLENOL® 8 Hour Caplets 50 Count Sold in the United States and Puerto Rico
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... Va. and WASHINGTON , ... Specialty Pharmacy (NASP) and SmartBrief recently partnered to deliver ... a snapshot of the top news in the industry. ... pharmacies, pharmaceutical and biotechnology manufacturers, GPOs, distributors and other ... resource will launch on April 27, 2015. ...
(Date:4/27/2015)... , April 27, 2015 Demonstrating the power ... announced that LifeScience Alley  will produce a world ... MD&M Minneapolis event, November 4-5, 2015, at the ... Minneapolis, MN. This combined 2015 Minneapolis ... manufacturers, suppliers, and business leaders all under one roof, ...
(Date:4/27/2015)... 2015 PAML announced today that the ... Axela, Inc. to develop multiplex assays focused on ... of the nation,s leading medical reference laboratories, and ... analysis for clinical diagnostics. Axela,s ... assay development serves as the foundation for novel ...
Breaking Medicine Technology:NASP and SmartBrief Partner on Specialty Pharmacy SmartBrief 2LifeScience Alley and MD&M Minneapolis partner for Minnesota Medtech Week 2LifeScience Alley and MD&M Minneapolis partner for Minnesota Medtech Week 3PAML and Axela Collaborate on Immune Status for Vaccine Preventable Diseases 2
... -- The Six-Month Primary Efficacy Endpoint ... Significantly Increased "ON" Time in,Levodopa-Treated Patients With mid- to Late-Stage ... Endpoints of the Study Analyzed to Date Were met in,Both ... a division of Merck KGaA, Darmstadt, Germany, and its,partner Newron ...
... NEW YORK, Feb. 2 A study led by ... has identified a gene associated with the development of ... With funding provided by the Dystonia Medical Research Foundation ... mutations in the THAP1 gene cause DYT6 dystonia in ...
Cached Medicine Technology:Merck Serono's Safinamide Significantly Improved Motor Function in Patients With Advanced Parkinson's Disease in a Phase III Pivotal Trial 2Merck Serono's Safinamide Significantly Improved Motor Function in Patients With Advanced Parkinson's Disease in a Phase III Pivotal Trial 3Merck Serono's Safinamide Significantly Improved Motor Function in Patients With Advanced Parkinson's Disease in a Phase III Pivotal Trial 4Merck Serono's Safinamide Significantly Improved Motor Function in Patients With Advanced Parkinson's Disease in a Phase III Pivotal Trial 5Merck Serono's Safinamide Significantly Improved Motor Function in Patients With Advanced Parkinson's Disease in a Phase III Pivotal Trial 6Genetic Research Leads to New Discovery in Understanding Rare Neurological Disorder 2
(Date:4/27/2015)... According to a recent report from ... chronic back pain, TMJ disorders are the second ... disability. In addition, the report revealed that TMJ disorders ... costing an estimated 4 billion dollars annually. , These ... seemingly unrelated symptoms such as headaches, neck pain, tenderness ...
(Date:4/27/2015)... Thanks to a $7.5 million grant from ... institutions, including American University, will operate in a new ... behavioral research aimed at ending the AIDS epidemic. , ... HIV or AIDS, according to the latest statistics. At ... over the age of 13 was living with HIV, ...
(Date:4/27/2015)... April 27, 2015 Doctors on Liens ... on a lien basis for over twenty years. So when ... the best doctor in the Fresno area , Doctors ... DC and his team of medical specialists. With a ... massage therapist, Dilanchian Chiropractic is now helping more ...
(Date:4/27/2015)... Church, VA (PRWEB) April 27, 2015 ... Integrity Issues Within Your Operations or Your Partners/Suppliers, **FDAnews ... p.m. EDT, http://www.fdanews.com/DataIntegrity , Data integrity issues ... the last few years., Uncovering data integrity issues within ... once data integrity issues come to light, remediating them ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 FMC Corporation’s ... exhibit its wide range of market leading ingredients and ... 7 in Geneva, Switzerland. Vitafoods Europe 2015 expects to ... countries showcasing the latest research in such areas as ... , FMC Health and Nutrition’s booth will feature ...
Breaking Medicine News(10 mins):Health News:Dentist in Graham NC Reveals that a Jaw Disorder May Be the Cause of Chronic Headaches and Back Pain 2Health News:D.C. Center for AIDS Research Established with New Grant from NIH 2Health News:D.C. Center for AIDS Research Established with New Grant from NIH 3Health News:Eminent Doctor Joins Forces with Doctors on Liens in Fresno 2Health News:FDAnews Announces — Data Integrity Problems on the Rise: Confronting Data Integrity Issues Within Your Operations or Your Partners/Suppliers Webinar, May 19, 2015 2Health News:FDAnews Announces — Data Integrity Problems on the Rise: Confronting Data Integrity Issues Within Your Operations or Your Partners/Suppliers Webinar, May 19, 2015 3Health News:FDAnews Announces — Data Integrity Problems on the Rise: Confronting Data Integrity Issues Within Your Operations or Your Partners/Suppliers Webinar, May 19, 2015 4Health News:FMC Health and Nutrition to Feature Epax® Brand Omega-3 Ingredients at Vitafoods Europe 2015 2
... ... some people have questioned if the HCG diet can be harmful. Dr Robert True addresses ... , ... Dr. Robert sees patients on a daily basis that he helps lose weight through his ...
... ... BtoB companies seeking a proven approach for lead cultivation with social media. , ... Portland, OR (PRWEB) March 24, 2010 -- ... Five Ways to Leads: How BtoBs Should Use Social Media , a complimentary Webinar event ...
... This release is available in Spanish . ... same area as the original tumour remains the strongest, independent ... who have been free of disease for a very long ... European Breast Cancer Conference (EBCC7). Dr Sven Mieog, MD, ...
... available in Spanish . Barcelona, Spain: ... goal in survival with new treatment should be to prolong ... might expect from using current best therapies, a researcher will ... today (Wednesday). This finding contrasts with doctors, perception that an ...
... the Barcelona Public Health Agency has revealed those sections of ... published in the journal Respiratory Research , shows that ... aged over 50 or infected with HIV. "Some patients ... of six months), resulting in a danger of them infecting ...
... the death of a loved one can provide much-needed consolation ... study in the April issue of the Journal of ... a relative to cancer took part in the study. Participants ... widows, widowers, daughters and sisters. Nine chose foot massage, eight ...
Cached Medicine News:Health News:HCG True Diet – Dr. Robert True Speaks About the Importance of Medical Supervision for HCG Diets 2Health News:Webinar Shares Proven Social Media Approach to BtoB Lead Generation 2Health News:Recurrence of breast cancer after more than 10 years is an important indicator of survival 2Health News:Recurrence of breast cancer after more than 10 years is an important indicator of survival 3Health News:What should be the goal of treatment in metastatic breast cancer? 2Health News:What should be the goal of treatment in metastatic breast cancer? 3Health News:Older people and those with HIV are more vulnerable to tuberculosis 2Health News:Hand and feet massages provide consolation for bereaved relatives 2
... patented ratchet design provides fingertip ratchet disengagement ... I Instrument program offers state-of-the-art quality in ... maintaining strength and durability. Low profile cutting ... joint spaces. Series I instruments are available ...
... ratchet design provides fingertip ratchet disengagement allowing ... Instrument program offers state-of-the-art quality in an ... strength and durability. Low profile cutting tips ... spaces. Series I instruments are available in ...
... patented ratchet design provides fingertip ratchet disengagement ... I Instrument program offers state-of-the-art quality in ... maintaining strength and durability. Low profile cutting ... joint spaces. Series I instruments are available ...
... A broad selection of procedurally specific ... and allow easy access to all ... variety of approaches.,Loop Handled Graspers feature ... holds tissue firmly without tearing or ...
Medicine Products: